These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 15353974)

  • 1. Pre-seroconversion immune status predicts the rate of CD4 T cell decline following HIV infection.
    van Asten L; Danisman F; Otto SA; Borghans JA; Hazenberg MD; Coutinho RA; Prins M; Miedema F
    AIDS; 2004 Sep; 18(14):1885-93. PubMed ID: 15353974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistent immune activation in HIV-1 infection is associated with progression to AIDS.
    Hazenberg MD; Otto SA; van Benthem BH; Roos MT; Coutinho RA; Lange JM; Hamann D; Prins M; Miedema F
    AIDS; 2003 Sep; 17(13):1881-8. PubMed ID: 12960820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunologic marker paths for seroconversion: single determinations of immunoglobulin A and beta 2-microglobulin are not adequate to estimate time of HIV infection. Multicohort Analysis Project Workshop. Part II.
    AIDS; 1994 Jul; 8(7):923-33. PubMed ID: 7946101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T cell receptor excision circle (TREC) content following maximum HIV suppression is equivalent in HIV-infected and HIV-uninfected individuals.
    Steffens CM; Smith KY; Landay A; Shott S; Truckenbrod A; Russert M; Al-Harthi L
    AIDS; 2001 Sep; 15(14):1757-64. PubMed ID: 11579236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in CD4 cell counts at seroconversion and decline among 5739 HIV-1-infected individuals with well-estimated dates of seroconversion.
    CASCADE Collaboration
    J Acquir Immune Defic Syndr; 2003 Sep; 34(1):76-83. PubMed ID: 14501798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T cell receptor excision circles and HIV-1 2-LTR episomal DNA to predict AIDS in patients not receiving effective therapy.
    Goedert JJ; O'Brien TR; Hatzakis A; Kostrikis LG;
    AIDS; 2001 Nov; 15(17):2245-50. PubMed ID: 11698697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunologic markers of AIDS progression: consistency across five HIV-infected cohorts. Multicohort Analysis Project Workshop. Part I.
    AIDS; 1994 Jul; 8(7):911-21. PubMed ID: 7946100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of recent thymic emigrants on progression of HIV-1 disease.
    Hatzakis A; Touloumi G; Karanicolas R; Karafoulidou A; Mandalaki T; Anastassopoulou C; Zhang L; Goedert JJ; Ho DD; Kostrikis LG
    Lancet; 2000 Feb; 355(9204):599-604. PubMed ID: 10696979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pre-AIDS mortality from natural causes associated with HIV disease progression: evidence from the European Seroconverter Study among injecting drug users.
    Prins M; Hernández Aguado IH; Brettle RP; Robertson JR; Broers B; Carré N; Goldberg DJ; Zangerle R; Coutinho RA; van den Hoek A
    AIDS; 1997 Nov; 11(14):1747-56. PubMed ID: 9386810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in T cell receptor excision DNA circle (TREC) levels in HIV type 1-infected subjects pre- and post-highly active antiretroviral therapy.
    Touloumi G; Pantazis N; Karafoulidou A; Mandalaki T; Goedert JJ; Kostrikis LG; Hatzakis A
    AIDS Res Hum Retroviruses; 2004 Jan; 20(1):47-54. PubMed ID: 15000698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical characteristics and prognostic value of acute retroviral syndrome among injecting drug users. Italian Seroconversion Study.
    Dorrucci M; Rezza G; Vlahov D; Pezzotti P; Sinicco A; Nicolosi A; Lazzarin A; Galai N; Gafà S; Pristerà R
    AIDS; 1995 Jun; 9(6):597-604. PubMed ID: 7662199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Geographical variation in disease progression in HIV-1 seroconverted injecting drug users in Europe?
    Prins M; Brettle RP; Robertson JR; Hernández Aguado I; Broers B; Carré N; Goldberg DJ; Zangerle R; Coutinho RA; van den Hoek A
    Int J Epidemiol; 1999 Jun; 28(3):541-9. PubMed ID: 10405862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progression of HIV: follow-up of Edinburgh injecting drug users with narrow seroconversion intervals in 1983-1985.
    Brettle RP; McNeil AJ; Burns S; Gore SM; Bird AG; Yap PL; MacCallum L; Leen CS; Richardson AM
    AIDS; 1996 Apr; 10(4):419-30. PubMed ID: 8728047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV disease progression in 854 women and men infected through injecting drug use and heterosexual sex and followed for up to nine years from seroconversion. Italian Seroconversion Study.
    Cozzi Lepri A; Pezzotti P; Dorrucci M; Phillips AN; Rezza G
    BMJ; 1994 Dec; 309(6968):1537-42. PubMed ID: 7819892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Injecting drug use is associated with a more rapid CD4 cell decline among treatment naïve HIV-positive patients in Indonesia.
    Meijerink H; Wisaksana R; Iskandar S; den Heijer M; van der Ven AJ; Alisjahbana B; van Crevel R
    J Int AIDS Soc; 2014; 17(1):18844. PubMed ID: 24388495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of telomere length and thymic output in fast and slow/non-progressors with HIV infection.
    Richardson MW; Sverstiuk A; Hendel H; Cheung TW; Zagury JF; Rappaport J
    Biomed Pharmacother; 2000 Feb; 54(1):21-31. PubMed ID: 10721459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-2 therapy and thymic production of naive CD4 T cells in HIV-infected patients with severe CD4 lymphopenia.
    Carcelain G; Saint-Mézard P; Altes HK; Tubiana R; Grenot P; Rabian C; de Boer R; Costagliola D; Katlama C; Debré P; Autran B
    AIDS; 2003 Apr; 17(6):841-50. PubMed ID: 12660531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of progression and non-progression in injecting drug users and homosexual men with documented dates of HIV-1 seroconversion. European Seroconverter Study and the Tricontinental Seroconverter Study.
    Prins M; Veugelers PJ
    AIDS; 1997 Apr; 11(5):621-31. PubMed ID: 9108944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is the clinical course of HIV-1 changing? Cohort study.
    Sinicco A; Fora R; Raiteri R; Sciandra M; Bechis G; Calvo MM; Gioannini P
    BMJ; 1997 Apr; 314(7089):1232-7. PubMed ID: 9154026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AIDS prognosis based on HIV-1 RNA, CD4+ T-cell count and function: markers with reciprocal predictive value over time after seroconversion.
    de Wolf F; Spijkerman I; Schellekens PT; Langendam M; Kuiken C; Bakker M; Roos M; Coutinho R; Miedema F; Goudsmit J
    AIDS; 1997 Dec; 11(15):1799-806. PubMed ID: 9412697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.